Latest Senior Health news from across the web.
(MedPage Today) -- The largest Cyclospora food poisoning outbreak in U.S. history is over, health officials said Friday. FDA officials said they are confident that all recalled iceberg lettuce related to this specific outbreak is off the market...
Read full article →(MedPage Today) -- A fifth of patients receiving treatment for neovascular (wet) age-related macular degeneration (AMD) stopped care without explanation during long-term follow-up in a large multicenter Canadian cohort. Overall, 527 of the 2,556...
Read full article →(MedPage Today) -- Note that some links may require registration or subscription. The fastest-growing Ebola outbreak on record in eastern Congo is rapidly spreading beyond its epicenter, the Africa CDC warned, and a seventh province is now involved...
Read full article →(MedPage Today) -- Last week, leading medical societies did something both unusual and indispensable: The American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and Infectious...
Read full article →A record number of hospitals are fully sharing data on the cost of their services, thanks to the CMS stepping up enforcement. But there’s still a ways to go, according to PatientRightsAdvocate.org.
Read full article →The funding could create a regulatory approval pathway for future applications of clinical-grade artificial intelligence.
Read full article →The study, published last week in JAMA, counters concerns that insurers are raising premiums to pad profits.
Read full article →(MedPage Today) -- The unique dual inflammation blockade of investigational lunsekimig showed promise for moderate-to-severe asthma in the phase II AIRCULES study. Targeting both thymic stromal lymphopoietin (TSLP) and interleukin (IL)-13, lunsekimig...
Read full article →(MedPage Today) -- Adding the BCL2 inhibitor venetoclax (Venclexta) to chemoimmunotherapy led to worse outcomes and excess mortality in patients with newly diagnosed double-hit lymphoma, phase II results from a randomized trial showed. Median...
Read full article →(MedPage Today) -- New multiple sclerosis (MS) patients treated with B-cell-depleting drugs or high-efficacy therapies had lower relapse rates and fewer brain lesions than those treated with oral drugs, but at 2 years, disability outcomes were...
Read full article →(MedPage Today) -- In cystic fibrosis, vanzacaftor-tezacaftor-deutivacaftor (VTD; Alyftrek) showed great potential for modifying the progression of disease in young children, according to the TIMBERLINE study. Assessing safety and tolerability...
Read full article →(MedPage Today) -- The graduate medical education (GME) software company Thalamus filed a lawsuit against its competitor Liaison International and ob/gyn leader Maya Hammoud, MD, MBA, over alleged anticompetitive conduct. Thalamus brought the...
Read full article →